Biopharma Stock Updates - 12/14/20

Data Updates:

$ALXN (+29%) - AstraZeneca to Acquire Alexion, Accelerating the Company's Strategic and Financial Development

$ARVN (+95%) - Arvinas Releases Interim Clinical Data Further Demonstrating the Powerful Potential of PROTAC® Protein Degraders ARV-471 and ARV-110

$ARMN (+1.6%) - Multiple VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at National Lipid Association (NLA) Scientific Sessions 2020, Including First COVID-19 Clinical Results

$BNTX (-15%) - Provide Data from German Phase 1/2 Study of COVID-19 Vaccine Candidate BNT162b2

$GMDA (-8.5%) - Update on Biologics License Application for Omidubicel

$MRNA (+0.5%) - Moderna Confirms Supply Agreement with the Ministry of Health to Supply Singapore with mRNA Vaccine Against COVID-19 (mRNA-1273)

Financial Updates:

$OCUL (+7.5%) - Announces public offering

$ARVN (+95%) - Announces public offering

$RCKT (-6%) - Closes public offering at $56/share

$TGTX (+3.5%) - Proposed Public Offering of Common Stock of $200,000,000

$MIRM (-5.5%) - Commencement of Public Offering of Common Stock of $75.0 million